A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Leflunomide D4 | CAS 1189987-23-2 - Request Quote

Picture of Leflunomide D4

Leflunomide D4

SZ CAT No:SZ-L032D01
CAS No
1189987-23-2
Mol.F.
C12H5D4F3N2O2
Mol.Wt.
274.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Leflunomide D4 is chemically 5-Methyl-N-(4-(trifluoromethyl)phenyl-2,3,5,6-d4)isoxazole-4-carboxamide. Leflunomide D4 is supplied with detailed characterization data compliant with regulatory guideline. Leflunomide D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Leflunomide.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1189987-23-2

Purchase 1189987-23-2

Order 1189987-23-2

Enquire 1189987-23-2

price of 1189987-23-2

1189987-23-2 Supplier

1189987-23-2 Manufacturer

1189987-23-2 Exporter

buy high quality Leflunomide D4

Purchase Leflunomide D4

Leflunomide D4 suppliers

Leflunomide D4 manufacturers

Leflunomide D4 price

Order Leflunomide D4

Enquire Leflunomide D4

Leflunomide D4 cost

Leflunomide D4 Supplier

Leflunomide D4 Distributor

Leflunomide D4 for Method Validation

Leflunomide Reference Standard

Leflunomide D4 for ANDA Filing

Leflunomide D4 for Forced Degradation Studies

Leflunomide D4 Identification Standards

Leflunomide D4 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,